ITGB2 and ovarian serous adenocarcinoma: Having demonstrated the potential relationship between ITGB2 and the immune infiltration in serous ovarian cancer patients via an integrated bioinformatics analysis, we deduced that this association may also be applicable to serous ovarian cancer patients.